Brief: Tenaya Therapeutics Reports Fourth Quarter And Year-End 2021 Results
March 23 (Reuters) - Tenaya Therapeutics Inc TNYA.O :
* TENAYA THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END
2021
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
* TENAYA THERAPEUTICS INC - EXPECTS CURRENT CASH,
EQUIVALENTS, ETC
WILL BE SUFFICIENT TO FUND CURRENT OPERATING PLAN AT LEAST INTO
H2 2023
Source text for Eikon: ID:nBw1pyf9Wa
Further company coverage: TNYA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Tenaya Therapeutics
See all newsBrief: Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment Of Mybpc3-Associated Hcm With TN-201 Gene Therapy Resulted In Consistent Signs Of Cardiac Remodeling And Reductions In Symptoms
Brief: Positive Interim Data From Cohorts 1 And 2 Of Tenaya's Ridge-1 Phase 1B/2 Clinical Trial Of TN-401
Tenaya Therapeutics Q1 net loss widens, misses analyst expectations
Brief: Tenaya Therapeutics Q1 Net Income USD -19.272 Million
Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027